  | Galgani, A.* , MARY, A.* , Lombardo, F., Martini, N., Scotto, M., Tognoni, G., Siciliano, G., Ceravolo, R., Giorgi, F. S.* , & HENEKA, M.*. (July 2025). Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 21 (7), 70434. doi:10.1002/alz.70434  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Haase, L., Belkacemi, A., Neises, L., Kiweler, N., Wesely, C., Huchzermeier, R., Bozic, M., Khakdan, A., Sánchez, M., MARY, A., Sachs, N., Winter, H., GLAAB, E., HENEKA, M., van der Vorst, E. P., Mittelbronn, M., Meiser, J., & SCHNEIDER, J. (2025). Modulation of the Acod1/itaconate pathway differentially affects atherosclerosis severity across genetic models and sexes. Journal of Clinical Investigation. doi:10.1172/JCI182472 Peer Reviewed verified by ORBi |
 | MARY, A., Barale, S., Eysert, F., Valverde, A., Lacas-Gervais, S., Bauer, C., Eddarkaoui, S., Buée, L., Buée-Scherrer, V., Checler, F., & Chami, M. (02 June 2025). Hampered AMPK-ULK1 cascade in Alzheimer's disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin. Alzheimer's Research and Therapy, 17 (1), 127. doi:10.1186/s13195-025-01772-0 Peer Reviewed verified by ORBi |
 | Owona, B. A.* , MARY, A.* , Messi, A. N., Ravichandran, K. A., Mbing, J. N., Pegnyemb, E., Moundipa, P. F., & HENEKA, M. (2024). Biflavonoid Methylchamaejasmin and Khaya grandifoliola Extract Inhibit NLRP3 Inflammasome in THP-1 Cell Model of Neuroinflammation. Molecular Neurobiology. doi:10.1007/s12035-024-04365-4 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (05 March 2024). Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer's Disease Patients? Environmental Science and Technology, 58 (9), 4181 - 4192. doi:10.1021/acs.est.3c10490 Peer Reviewed verified by ORBi |
 | MARY, A., Mancuso, R., & HENEKA, M. (29 February 2024). Immune Activation in Alzheimer Disease. Annual Review of Immunology, 42 (1). doi:10.1146/annurev-immunol-101921-035222 Peer Reviewed verified by ORBi |
 | TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients? (2). ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58891. doi:10.26434/chemrxiv-2023-6j2gm-v2 |
 | TALAVERA ANDUJAR, B., MARY, A., VENEGAS MALDONADO, C. J., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (21 September 2023). YoungNMC 2023: "Challenges in Developing Non-target Exposomics and Metabolomics Workflows for Cerebrospinal Fluid from Alzheimer's disease and Mild Cognitive Impairment" [Paper presentation]. YoungNMC Symposium, Nijmegen, Netherlands. doi:10.5281/ZENODO.8364324 Peer reviewed |
 | TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E., HENEKA, M., & SCHYMANSKI, E. (2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer’s Disease on Cerebrospinal Fluid. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/57734. doi:10.26434/chemrxiv-2023-6j2gm |
 | TALAVERA ANDUJAR, B., MARY, A., Cheng, T., Zaslavsky, L., Bolton, E. E., HENEKA, M., & SCHYMANSKI, E. (07 June 2023). Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer's Disease on Cerebrospinal Fluid [Poster presentation]. 19th Annual International Conference of the Metabolomics Society, Niagara Falls, Canada. doi:10.5281/ZENODO.8017622 Peer reviewed |
 | MARY, A., Eysert, F., Checler, F., & Chami, M. (2023). Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches. Molecular Psychiatry, 28 (1), 202-216. doi:10.1038/s41380-022-01631-6 Peer Reviewed verified by ORBi |
 | Vaillant-Beuchot, L.* , MARY, A.* , Pardossi-Piquard, R., Bourgeois, A., Lauritzen, I., Eysert, F., Kinoshita, P. F., Cazareth, J., Badot, C., Fragaki, K., Bussiere, R., Martin, C., Mary, R., Bauer, C., Pagnotta, S., Paquis-Flucklinger, V., Buée-Scherrer, V., Buée, L., Lacas-Gervais, S., ... Chami, M. (2021). Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains. Acta Neuropathologica, 141 (1), 39-65. doi:10.1007/s00401-020-02234-7 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | MARY, A.* , Vaillant-Beuchot, L.* , Checler, F., & Chami, M. (2021). Dysfonction mitochondriale et défaillance de la mitophagie dans la maladie d’Alzheimer. Medecine sciences : M/S, 37 (10), 843-847. doi:10.1051/medsci/2021133 Peer reviewed* These authors have contributed equally to this work. |
 | Eysert, F., Kinoshita, P. F., MARY, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020). Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer's Disease. International Journal of Molecular Sciences, 21 (24). doi:10.3390/ijms21249521 Peer Reviewed verified by ORBi |
 | Bussiere, R., Oulès, B., MARY, A., Vaillant-Beuchot, L., Martin, C., El Manaa, W., Vallée, D., Duplan, E., Paterlini-Bréchot, P., Alves Da Costa, C., Checler, F., & Chami, M. (2019). Upregulation of the Sarco-Endoplasmic Reticulum Calcium ATPase 1 Truncated Isoform Plays a Pathogenic Role in Alzheimer's Disease. Cells, 8 (12). doi:10.3390/cells8121539 Peer Reviewed verified by ORBi |
Dataset: